In this issue:
- CREST-2 analysis: Experts focus on medical management, trial design and plaque imaging following the presentation of landmark trial data
- Opinion: Vascular Society of Great Britain and Ireland (VSGBI) president Keith Jones (Camberley, UK) shares his thoughts on the SWHSI-2 trial results
- Radiation safety: Patrick Muck (Cincinnati, USA) examines the latest technologies available for radiation protection in the vascular space amid a “meteoric” rise in endovascular procedures
- In profile: Marianne Brodmann (Graz, Austria)
- Research highlights from the 2025 Vascular Interventional Advances (VIVA) conference (2–5 November, Las Vegas, USA), 2025 Paris Vascular Insights (PVI) Course (11–13 December, Paris, France) and more
